# DESCRIPTION

- acknowledge government support

## TECHNICAL FIELD OF THE INVENTION

- define antibody generation

## BACKGROUND OF THE INVENTION

- motivate cancer treatment

## SUMMARY OF THE INVENTION

- introduce isolated molecule

## DETAILED DESCRIPTION OF THE INVENTION

- motivate targeting HLA-peptide complexes
- describe generation of antibody variable regions
- outline library construction and screening methods
- discuss applications of identified molecules
- summarize advantages and significance of the invention

### EXAMPLE 1

- describe cell lines and culture conditions
- construct phage display library
- prepare peptides and HLA-monomers
- select phages binding to mutant KRAS-HLA-A2 and mutant EGFR-HLA-A3
- perform affinity maturation of D10
- describe ELISA protocol
- outline scFv production and purification
- detail antibody production and purification
- describe cell staining and cytotoxicity assays
- outline affinity and koff measurements

### EXAMPLE 2

- design scFv library

### EXAMPLE 3

- select target and competitive strategy

### EXAMPLE 4

- evaluate selected phage clones

### EXAMPLE 5

- identify phage binding to different MANA

### EXAMPLE 6

- test selective binding to cells

### EXAMPLE 7

- generate full-length MANAbody

### EXAMPLE 8

- modify phage panning protocols

### EXAMPLE 9

- describe phage selection for F10 clone
- demonstrate multiple scFv candidates

